Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Innovotech ( (TSE:IOT) ).
Innovotech Inc. announced that its invention involving antimicrobial silver compounds, specifically InnovoSIL™-1 silver, has been granted a European patent. This patent covers the use of these compounds in medical devices, offering broad-spectrum activity against bacterial and fungal biofilms and providing a potential solution to antibiotic resistance. The patent opens opportunities for Innovotech to license these applications to European industry partners, enhancing their products with antiplanktonic, antiviral, anti-adherence, or antibiofilm properties.
More about Innovotech
Innovotech Inc. is a Canadian biotechnology company that owns proprietary intellectual property, conducts contract research, and provides proprietary devices for testing various applications in microbiology.
YTD Price Performance: 0.0%
Average Trading Volume: 14,976
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: C$8.95M
See more insights into IOT stock on TipRanks’ Stock Analysis page.
